Overcome the limitations of conventional transfection with MaxCyte electroporation

Are low gene editing efficiency or gene expression levels preventing your research from advancing? Is your transfection method killing your cells? Are you struggling to reproduce your initial results when you need to scale-up to transfect millions of cells instead of thousands?

Join us as we explore how MaxCyte's electroporation technology can help you to overcome these challenges, and more.

Learn about how traditional delivery methods, such as chemical transfection and retroviral transduction, compare to electroporation for transient and stable engineering with plasmid DNA, mRNA, and CRISPR-RNPs. We will also introduce new approaches for larger-scale electroporation that enable faster workflows, which can save researchers weeks of development time.

This webinar is for scientists who are struggling to meet the demands of cell engineering in various applications, including cell therapy, cell-based screening and bioproduction.